Protective effects of erdosteine against
β
Ersin FadillioΗ§lu; Hasan ErdoΗ§an; Sadik SΓΆΗ§ΓΌt; Irfan Kuku
π
Article
π
2003
π
John Wiley and Sons
π
English
β 83 KB
π 1 views
## Abstract The usefulness of doxorubicin (DXR) is limited by its cardiotoxicity. In order to improve future DXR therapy by using a new antioxidant agent, an experimental study was designed. This study was undertaken to determine whether DXRβinduced cardiotoxicity is prevented by erdosteine, a muco